Health Tech Capitol | Primorigen Biosciences Acquired by Nucleus Biologics
16827
post-template-default,single,single-post,postid-16827,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Primorigen Biosciences Acquired by Nucleus Biologics

06 Aug Primorigen Biosciences Acquired by Nucleus Biologics

Posted at 10:45h in Uncategorized by
0 Likes

Primorigen Biosciences has been acquired by Nucleus Biologics, a leader in precision cell culture, the company announced today.

“The exceptionally strong fit of the Nucleus and Primorigen product portfolios provide a compelling value proposition for customers seeking more complete solutions for cell biology research and production,” Primorigen CEO Chuck Oehler said in a statement.

According to a release, the addition of Primorigen’s Vitronectin XF and platform recombinant protein production technology will play a role in Nucleus’ strategy of offering traceable, reproducible and xeno-free cell culture ecosystems for the cell and gene therapy space.

Read more at Madison Startups

No Comments

Sorry, the comment form is closed at this time.